In our latest blog, we look at PTAB proceedings involving #biologics to reveal insights about where biologics litigation is headed. Learn more:

In our latest blog reporting on #BPCIA litigation, we move beyond products and patents to see which courts, judges, and counsel are involved in the action. Read the new analysis:

WIT represents testifying #experts who understand the technical, regulatory, and commercial complexities driving innovation in healthcare technology and medical devices. Learn more:

In a dispute involving electronic trading systems for order routing and execution, a U.S. securities exchange brought claims of patent infringement and trade secret misappropriation against a competing exchange group. Read the case study to learn more:

Happy 4th of July from all of us at WIT Legal!

Read the report:

New research from the DOAR Research Center offers insight into juror views on Big Tech. While 73% of respondents reported positive opinions of large #tech companies, attitudes varied significantly by brand, with Meta viewed most negatively.

In the latest edition of our #ITC report series, we offer an in-depth analysis of Administrative Law Judge MaryJoan McNamara's background, experience, and her work as a Commission judge. Download the report: 

As we commemorate Juneteenth, we honor the legacy and resilience of the Black community and reaffirm our commitment to advancing equity and justice. #juneteenth2025

What’s driving BPCIA litigation in biologics? We analyzed 10+ years of filings to identify the products, patents, and therapeutic areas most often at the center of disputes. Read the report:

In a shareholder derivative complaint involving allegations of executive oversight failure, the plaintiff turned to WIT for a banking enforcement expert. Read the case study:

Happy Pride Month! At WIT, we celebrate inclusion, equity, and the right to live—and work—with pride. This month and every month, we stand with the LGBTQ+ community.

Learn more about our pharmaceutical expert team and how we support counsel in complex litigation:

WIT has been involved in some of the most prominent disputes associated with vaccines and drugs, including dozens of #pharmaceutical lawsuits associated with the opioid crisis, the pneumococcal vaccine, the mumps vaccine, and the influenza vaccine.

Subscribe to stay up-to-date:

A closer look at ALJ McNamara’s 2024 assignments reveals a strong focus on Consumer Goods and Life Sciences—each representing nearly 30% of her docket. Get more insights on ALJ McNamara's activity at the ITC in our next installment of WIT's ITC ALJ Report.

WIT represents #experts in the most active areas of litigation today. We build teams of experts who have expertise in industries where legal #disputes are accelerating, including automotive, fintech, wireless, and more. Learn more about our experts:

The next installment of WIT’s ITC ALJ Report will feature insights into ALJ MaryJoan McNamara’s activity at the Commission. Stay tuned.

To better understand the pain points affecting supply chain operations across industries, we sat down with Dr. Robert Handfield to discuss the most pressing challenges companies face today. Learn more:

Today, we honor and remember the brave service members who gave their lives in defense of our country. Their sacrifice makes our freedoms, and the pursuit of justice, possible. #MemorialDay2025